RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Medlab Clinical Stock

Medlab Clinical Net Income 2025

Medlab Clinical Net Income

-2.51 M AUD

Ticker

MDC.AX

ISIN

AU000000MDC8

WKN

A14R7W

In 2025, Medlab Clinical's profit amounted to -2.51 M AUD, a 17.99% increase from the -2.13 M AUD profit recorded in the previous year.

The Medlab Clinical Net Income history

YEARNET INCOME (undefined AUD)
2027e-
2026e-
2025e-
2024-
2023-
2022-
2021-
2020-
2019-
2018-
2017-
2016-
2015-
2014-

Medlab Clinical Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into Medlab Clinical, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Medlab Clinical from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Medlab Clinical’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Medlab Clinical. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Medlab Clinical’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Medlab Clinical’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Medlab Clinical’s growth potential.

Medlab Clinical Revenue, EBIT and net profit per share

DateMedlab Clinical RevenueMedlab Clinical EBITMedlab Clinical Net Income
2027e20.9 M undefined0 undefined-9.91 M undefined
2026e17.9 M undefined-14.2 M undefined-8.06 M undefined
2025e6.87 M undefined-5.96 M undefined-2.51 M undefined
202414,600 undefined-2.26 M undefined-2.13 M undefined
2023943,700 undefined-7.22 M undefined-6.78 M undefined
20221.33 M undefined-8.37 M undefined-7.16 M undefined
2021757,900 undefined-10.93 M undefined-6.78 M undefined
20202.92 M undefined-13.74 M undefined-13.4 M undefined
20197.8 M undefined-8.39 M undefined-8.09 M undefined
20185.55 M undefined-4.7 M undefined-4.57 M undefined
20174.45 M undefined-3.82 M undefined-3.66 M undefined
20162.61 M undefined-3.71 M undefined-3.49 M undefined
20151.27 M undefined-3.9 M undefined-3.55 M undefined
2014590,000 undefined-1.8 M undefined-1.61 M undefined

Medlab Clinical stock margins

The Medlab Clinical margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Medlab Clinical. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Medlab Clinical.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Medlab Clinical's sales revenue. A higher gross margin percentage indicates that the Medlab Clinical retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Medlab Clinical's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Medlab Clinical's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Medlab Clinical's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Medlab Clinical. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Medlab Clinical's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Medlab Clinical Margin History

Medlab Clinical Gross marginMedlab Clinical Profit marginMedlab Clinical EBIT marginMedlab Clinical Profit margin
2027e100 %0 %-47.44 %
2026e100 %-79.33 %-45.04 %
2025e100 %-86.76 %-36.6 %
2024100 %-15,452.05 %-14,593.15 %
202390.35 %-765.58 %-718.28 %
202273.37 %-630.59 %-539.66 %
202193.17 %-1,442.01 %-895.1 %
20202.95 %-469.67 %-458.18 %
201959.64 %-107.57 %-103.79 %
201863.62 %-84.8 %-82.4 %
201761.2 %-85.96 %-82.26 %
201666.97 %-142.13 %-133.73 %
201592.05 %-307.86 %-280.59 %
201498.31 %-305.08 %-272.88 %

Medlab Clinical Aktienanalyse

What does Medlab Clinical do?

Medlab Clinical Ltd is an innovative biotechnology company focused on the development and commercialization of medical products and services. The company was founded in Australia in 2012 and is now based in Sydney. Since its founding, Medlab has established itself as a leading provider of diagnostic and therapeutic products. Medlab's business model consists of three different divisions. The first division is pharmaceutical development, where Medlab works on the development of new medications for the treatment of conditions such as fibromyalgia, pain, or ADHD. Medlab is particularly innovative in the development of medications based on the use of cannabinoids that are approved for medical use. The second division of Medlab is the research and development of nutritional supplements. The company works on the development of innovative products to improve general well-being and support health. An example is the nutritional supplement NRGBiotic, which contains special probiotic bacteria that help regulate the intestinal flora and thereby strengthen the immune system. The third division of Medlab is clinical diagnostics. The company offers various medical diagnostic tests, such as the test for food intolerances. This test is based on a blood sample and allows for targeted dietary changes in individuals with intolerance. Medlab aims to improve people's lives by developing and providing innovative products and services for medical care. Medlab's products are designed to promote the health and well-being of patients and customers and improve their quality of life. One outstanding product from Medlab is NanoCBD, an innovative form of cannabinoid delivery for medical purposes. The advantage of NanoCBD is that it has increased bioavailability due to the nanoparticles, resulting in faster and more effective action than conventional CBD products. Another product from Medlab is the pain medication NanaBis, which works faster and more effectively than other pain medications due to its unique formulation. Thanks to its special composition, NanaBis can also be taken by patients with severe chronic pain who do not respond to other pain medications. Medlab has established itself as a global company and is present worldwide. The company maintains partnerships and collaborations with renowned research institutions and doctors in Europe, North America, Australia, and Asia. Medlab works closely with medical professionals to ensure that the company's products and services meet the highest quality standards and meet the needs of patients and customers. Overall, Medlab Clinical Ltd has established itself as an innovative and reliable company in the medical industry. With its clear focus on the development of innovative medications, nutritional supplements, and diagnostic systems, Medlab significantly contributes to improving the healthcare system and increasing the well-being of people worldwide. Medlab Clinical ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Net Income Details

Understanding Medlab Clinical's Profit Margins

The profit margins of Medlab Clinical represent the net income earned after deducting all operational expenses, costs, and taxes from the revenue. This figure is a clear indicator of Medlab Clinical's financial health, operational efficiency, and profitability. Higher profit margins signify better cost management and income generation capabilities.

Year-to-Year Comparison

Evaluating Medlab Clinical's profit on a yearly basis can offer significant insights into its financial growth, stability, and trends. A consistent increase in profit suggests improved operational efficiency, cost management, or increased revenue, while a decrease may indicate rising costs, declining sales, or operational challenges.

Impact on Investments

Medlab Clinical's profit figures are critical for investors who are aiming to understand the company's financial standing and future growth prospects. Increased profits often lead to higher stock valuations, boosting investor confidence and attracting more investments.

Interpreting Profit Fluctuations

When Medlab Clinical’s profit increases, it often indicates enhanced operational efficiency or increased sales. In contrast, a decline in profit can signal operational inefficiencies, increased costs, or competitive pressures, necessitating strategic interventions to boost profitability.

Frequently Asked Questions about Medlab Clinical stock

How much profit has Medlab Clinical made this year?

Medlab Clinical has made -2.51 M AUD this year.

How has the profit developed compared to last year?

The profit has increased by 17.99% compared to last year increased

What impact do the earnings have on the shareholders?

An increase in earnings is usually seen as a positive indicator for shareholders as it means that the company is generating profits.

How does Medlab Clinical publish its earnings?

Medlab Clinical publishes its earnings in the form of quarterly or annual reports.

Which financial indicators are included in the quarterly or annual reports?

The quarterly or annual reports contain information about sales and profit, cash flow, balance sheet, and other fundamentals.

Why is it important for investors to know the earnings of Medlab Clinical?

The profits of Medlab Clinical are an important indicator of the financial health of the company and can help investors decide whether they want to invest in the company or not.

How can one learn more about the earnings of Medlab Clinical?

You can learn more about the earnings of Medlab Clinical by reviewing the quarterly or annual reports or following the company presentations.

How much dividend does Medlab Clinical pay?

Over the past 12 months, Medlab Clinical paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Medlab Clinical is expected to pay a dividend of 0 AUD.

What is the dividend yield of Medlab Clinical?

The current dividend yield of Medlab Clinical is .

When does Medlab Clinical pay dividends?

Medlab Clinical pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Medlab Clinical?

Medlab Clinical paid dividends every year for the past 0 years.

What is the dividend of Medlab Clinical?

For the upcoming 12 months, dividends amounting to 0 AUD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Medlab Clinical located?

Medlab Clinical is assigned to the 'Health' sector.

Wann musste ich die Aktien von Medlab Clinical kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Medlab Clinical from 7/14/2025 amounting to 0 AUD, you needed to have the stock in your portfolio before the ex-date on 7/14/2025.

When did Medlab Clinical pay the last dividend?

The last dividend was paid out on 7/14/2025.

What was the dividend of Medlab Clinical in the year 2024?

In the year 2024, Medlab Clinical distributed 0 AUD as dividends.

In which currency does Medlab Clinical pay out the dividend?

The dividends of Medlab Clinical are distributed in AUD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Medlab Clinical

Our stock analysis for Medlab Clinical Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Medlab Clinical Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.